Subjective, clinical and EMG effects of biofeedback and splint treatment

Area of Science:

• Neurology
• Biomedical Engineering
• Pain Management

Background:

• Myofascial Pain Dysfunction (MPD) significantly impacts patients' quality of life.
• Current treatments for MPD include splints and behavioral therapies.
• The efficacy of biofeedback for MPD requires further investigation.

Purpose of the Study:

• To evaluate the effectiveness of electromyography (EMG) biofeedback for treating MPD.
• To compare biofeedback therapy with traditional splint treatment and a control group.
• To analyze changes in masseter muscle activity during biofeedback intervention.

Main Methods:

• Patients with MPD were assigned to three groups: EMG biofeedback, nightly splint, or no treatment.
• Biofeedback training involved maintaining constant EMG masseter activity levels.
• Clinical dysfunction, subjective symptoms, and EMG activity were measured.

Main Results:

• The biofeedback group demonstrated significantly greater improvement in clinical dysfunction and pain symptoms than the splint or control groups.
• The splint group showed no significant difference in outcomes compared to the control group.
• EMG analysis revealed a shift towards increased trained masseter muscle contribution during biofeedback, particularly at high task levels.

Conclusions:

• EMG biofeedback is a more effective treatment for MPD than traditional splint therapy.
• Improved perceived control may be a key mechanism underlying biofeedback treatment success.
• Further research should explore the long-term generalization of biofeedback effects in non-feedback situations.